Skip to main content

Table 3 Age-adjusted 5-year relative survival (RS) for the period 2002-2006 by histologic subtypes and stage for endometrial cancer patients diagnosed in Germany, 1997-2006

From: Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage

Histologic subtypes Stage
  With complete stage information No stage information
  Overall Localized Regional Distant   
  N (%b) RS (SE) N (%c) RS (SE) N (%c) RS (SE) N (%c) RS (SE) N (%d) RS (SE)
Overall 13,456 (100) 81.0 (0.4) 11,634 (86) 91.2 (0.7) 814 (6) 50.5 (3.1) 1,008 (7) 19.8 (2.0) 17,450 (56) 79.5 (0.6)
Adenocarcinoma 12,630 (94) 83.9 (0.4) 11,097 (88) 92.2 (0.7) 736 (6) 50.7 (3.3) 797 (6) 20.0 (2.1) 15,643 (55) 83.3 (0.6)
Adenocarcinoma NOS 4,161 (31) 84.7 (0.7) 3,652 (88) 93.7 (1.1) 221 (5)   288 (7) 18.4 (3.3) 6,266 (60) 83.9 (0.9)
Papillary/clear cell 664 (5) 68.0 (2.2) 523 (79) 83.0 (3.0) 61 (9) 14.0 (4.9) 80 (12) 10.4 (5.0) 807 (55) 70.1 (2.7)
Mucinous/Squamous metaplasia 440 (3) 91.1 (2.2) 388 (88) 96.9 (3.2) 28 (6)   24 (5)   514 (54) 90.8 (2.9)
Adenosquamous 443 (3) 75.0 (2.5) 367 (83) 86.1 (3.7) 35 (8)   41 (9)   414 (54) 72.9 (3.7)
Endometrioid 6,499 (48) 86.0 (0.7) 5,841 (90) 92.9 (1.0) 344 (5) 57.2 (4.9) 314 (5) 22.3 (3.5) 7,151 (52) 84.9 (0.9)
Other adenocarcinoma 423 (3) 68.3 (2.5) 326 (77) 76.8 (4.4) 47 (11)   50 (11) 5.6 (4.5) 491 (54) 71.6 (3.4)
Sarcoma 521 (4) 43.1 (1.8) 350 (67) 61.8 (4.4) 48 (9)   123 (24) 13.7 (4.0) 1,161 (69) 40.1 (2.1)
  1. Abbreviations: NOS = not otherwise specified; RS = point estimates of relative survival (%); SE = standard error (percent units);
  2. a unstable point estimates of RS (SE > 5 percent units) were not reported;
  3. b % of histology;
  4. c % of those with complete stage information;
  5. d % of cases without stage information.